一项前瞻性纵向研究:角膜滞后性作为青光眼中心视野进展危险因素的评估
前瞻性队列研究纳入143例受试者共248只眼,平均随访4.8年,最少5次访视并完成10-2与24-2视野检查。多变量趋势分析显示较低角膜滞后性与10-2平均偏差下降更快相关(每降低1 mmHg为0.07 dB/年,P < .001),与24-2平均偏差无关(P = .490);事件分析显示较低角膜滞后性与10-2视野进展可能性增加相关(每降低1 mmHg比值比=1.35,P = .025)。作者认为较低角膜滞后性与中心视野进展风险有统计学显著但相对较小的增加相关。
要点
- 较低角膜滞后性与10-2平均偏差下降更快相关(每1 mmHg为0.07 dB/年,P < .001)。
- 较低角膜滞后性与10-2视野进展可能性增加相关(每1 mmHg比值比=1.35,P = .025)。
- 角膜滞后性与24-2平均偏差变化无显著关联(P = .490)。
核心结论
- 较低角膜滞后性与10-2测试网格上中心视野进展风险有统计学显著但相对较小的增加相关。
- 鉴于中心视野损害对生活质量有重大影响,作者认为临床医生应考虑使用角膜滞后性评估原发性开角型青光眼患者(包括早期病变者)的进展风险。
研究设计与样本
- 前瞻性队列研究,纳入143例受试者共248只眼,包括疑似青光眼和青光眼患者。
- 受试者平均随访4.8年,最少完成5次访视的10-2和24-2视野检查。
- 采用单变量和多变量线性混合效应模型分析10-2与24-2平均偏差随时间变化率的相关特征。
- 采用混合效应逻辑回归评估基于聚类点wise线性回归标准的事件性10-2视野进展可能性增加的相关特征。
主要发现
- 单变量趋势分析中,角膜滞后性与10-2及24-2视野进展显著相关。
- 多变量趋势分析中,较低角膜滞后性与10-2平均偏差下降更快相关(每1 mmHg为0.07 dB/年,P < .001),与24-2平均偏差无关(P = .490)。
- 多变量事件分析中,较低角膜滞后性与10-2视野进展可能性增加相关(每降低1 mmHg比值比=1.35,P = .025)。
- 在基线为早期青光眼损害(基线24-2平均偏差≥-6 dB)的眼中发现相似结果。
关键数值与推荐
- 事件性10-2视野进展基于聚类点wise线性回归标准定义。
- 早期青光眼损害定义为基线24-2平均偏差≥-6 dB。
临床怎么用
- 作者认为临床医生应考虑使用角膜滞后性评估原发性开角型青光眼患者(包括早期病变者)的进展风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the role of corneal hysteresis (CH) as a risk factor of central visual field (VF) progression in a cohort of glaucoma suspect and glaucoma patients. DESIGN: Prospective cohort study. METHODS: Two hundred forty-eight eyes of 143 subjects who were followed for an average of 4.8 years with a minimum of 5 visits with 10-2 and 24-2 VF tests were included. Univariable and multivariable linear mixed-effects models were used to identify characteristics associated with the rate of change over time in 10-2 and 24-2 mean deviation (MD). Mixed-effects logistic regression was used to evaluate characteristics associated with an increased likelihood of event-based 10-2 VF progression based on the clustered pointwise linear regression criterion. RESULTS: CH was significantly associated with 10-2 and 24-2 VF progression in the univariable trend-based analysis. In multivariable trend-based analyses, lower CH was associated with a faster rate of decline in 10-2 MD (0.07 dB/y per 1 mm Hg, P < .001) but not with 24-2 MD (P = .490). In multivariable event-based analysis, lower CH was associated with an increased likelihood of 10-2 VF progression (odds ratio = 1.35 per 1 mm Hg lower, P = .025). Similar results were found in eyes with early glaucomatous damage at the baseline (baseline: 24-2 MD ≥ -6 dB). CONCLUSIONS: Lower CH was associated with a statistically significant, but relatively small, increased risk of central VF progression on the 10-2 test grid. Given the substantial influence of central VF impairment on the quality of life, clinicians should consider using CH to assess the risk of progression in patients with primary open-angle glaucoma including those with early disease.
引用
- Kamalipour A, Moghimi S, Eslani M, et al. A Prospective Longitudinal Study to Investigate Corneal Hysteresis as a Risk Factor of Central Visual Field Progression in Glaucoma. Am J Ophthalmol. 2022. PMID: 35278360. doi:10.1016/j.ajo.2022.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。